The United States Food and Drug Administration (FDA) has appointed Brian A. King as the new director of the Center for Tobacco Products (CTP).
After an intensive executive search, I have chosen Dr. Brian A. King to serve as the new director for the FDA's Center for Tobacco Products," wrote Robert Califf on Twitter. "Dr. King brings impressive expertise in tobacco prevention and control, and has over 10 years of experience working at the CDC, making him well-versed in the operations of the FDA.
King is the Deputy Director of Research Translation at the Smoking and Health Office (OSH) of the National Center for Chronic Disease Prevention and Health Promotion at the Centers for Disease Control and Prevention (CDC). In this role, he is responsible for providing scientific leadership and technical expertise to the federal lead agency CDC/OSH for comprehensive tobacco prevention and control efforts.
In 2010, King joined the Centers for Disease Control and Prevention as an Epidemic Intelligence Service officer. Prior to this, he worked at the Roswell Park Comprehensive Cancer Center in Buffalo, New York, as a research affiliate in cancer prevention and population sciences division. During his time at Roswell Park, his main research focused on tobacco prevention and control.
For the past 15 years, King has been dedicated to providing reliable scientific evidence to inform tobacco control policies, effectively communicating this information to key stakeholders including decision makers, media, and the general public. He has authored or co-authored over 200 peer-reviewed scientific articles on tobacco prevention and control, was the author of the Surgeon General's 50th anniversary report on smoking and health, and was the lead author for the Centers for Disease Control and Prevention's 2014 update to the evidence-based national guidelines for comprehensive tobacco control programs. King also served as a senior editor for the 2016 Surgeon General's report on youth and young adult e-cigarette use and the 2020 Surgeon General's report on quitting smoking. He was also a senior official for the CDC's emergency response to the 2019 outbreak of lung injury associated with e-cigarette or vaping product use.
King holds a Doctorate in Epidemiology and a Master's Degree in Public Health from the State University of New York at Buffalo.
Source: Tobacco Reporter.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
